Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?

  • R. B. Oliveira, A. L.E. Cancela, F. G. Graciolli, L. M. Dos Reis, S. A. Draibe, L. Cuppari, A. B. Carvalho, V. Jorgetti, M. E. Canziani, R. M.A. Moyses
  • Clinical Journal of the American Society of Nephrology, November 2009, American Society of Nephrology
  • DOI: 10.2215/cjn.05420709

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Rosa MA Moyses